May 15th, 2008
The Netherlands, which combines mandatory universal health insurance with competition among private health insurers, has been frequently cited as a possible model for reform in the United States. You can read Wynand van de Ven and Frederik Schut’s examination of the Dutch experience (free access until May 27) in the May/June issue of Health Affairs, a thematic volume on health reform that was published May 13. Read the rest of this entry »
Posted in
All Categories, Europe, Health Reform |
Post a Comment
|
May 14th, 2008
By proposing to move away from the employer-based health care system to one emphasizing the individual market, Sen. John McCain (AZ), the presumptive Republican presidential nominee, has set the stage for health care to become part of a major debate about government and the marketplace during this year’s election, Robert Blendon said May 5.
Blendon, a professor of health policy and political analysis at Harvard University and director of the Harvard Program on Public Opinion and Health and Social Policy, spoke during a conference call moderated by Health Affairs editor-in-chief Susan Dentzer on the role of health reform in the presidential election. Other participants included Robert Laszewski, the president of Health Policy and Strategy Associates Inc. and the author of the widely respected blog Health Care Policy and Marketplace Review; and Julie Rovner, a health policy correspondent for National Public Radio and a contributing editor for National Journal’s CongressDaily. Health Affairs organized the call in connection with the publication of its May/June issue, a thematic issue on health reform. Click here for the full transcript of the call. Read the rest of this entry »
Posted in
All Categories, Health Reform, Politics, Public Opinion |
Post a Comment
|
May 5th, 2008
What role will the issue of health care reform play in the 2008 presidential election? How would the candidates control rising health costs and cover the uninsured, and how will the economic downturn affect efforts to expand access? Would the candidates’ reform proposals fix the health system’s flaws? What lessons can be drawn from previous health care reform efforts?
Join representatives from the Clinton, Obama and McCain presidential campaigns to tackle these and other questions at a Tuesday, May 13 briefing highlighting the May/June issue of Health Affairs, which focuses on health reform. Susan Dentzer, the journal’s Editor-in-Chief, will moderate the briefing, which will take place from 8:45 AM until noon at the Willard Hotel. Leading political pollsters Celinda Lake and Bill McInturff will discuss the prospects for health reform. Congressional Budget Office Director Peter Orszag and Jason Furman of the Brookings Institution will examine the potential of different strategies, from tax credits to individual mandates, to reduce costs and improve quality and access. Read the rest of this entry »
Posted in
Cost, Coverage, Health Reform, Politics |
Post a Comment
| 2 Trackbacks
April 29th, 2008
UnitedHealth Group officials may have been laying protective cover for themselves when they attributed poor first-quarter earnings to a sagging economy last week. But that doesn’t mean it isn’t also true, as United said, that business is bad because the company’s products are getting too expensive for a growing number of workers and companies. Coming within weeks of similar announcements by WellPoint and Aetna, United’s bad news represents a conundrum for any candidate who wants to talk about expanding coverage in 2009 — and most of them do. Read the rest of this entry »
Posted in
All Categories, Coverage, Health Care Costs, Health Reform, Politics |
1 Comment
|
Show Commenters
|
April 16th, 2008
In interviews with Health Affairs, government ministers in Germany and the Netherlands talk up market-oriented refinements to their universal health insurance systems for the future. But the news from Europe isn’t all happy: an unsettling survey in the United Kingdom finds that some physicians believe that the market will unravel the government-owned and -operated National Health Service (NHS) in the next decade.
The online poll of more than 500 general practitioners (GPs) conducted by Pulse, which describes itself as “UK’s leading medical weekly,” found that 84% believed that the NHS would not exist “as we know it” in ten years’ time and that only one-third believe that the NHS will be free at the point of use in the same amount of time. Read the rest of this entry »
Posted in
All Categories, Competition, Coverage, Europe, Global Health, Health Reform |
Post a Comment
|
April 9th, 2008
It’s been nearly five years since the President’s New Freedom Commission on Mental Health issued its final report. The report affirmed the possibility of recovery and the effectiveness of available treatments for many conditions. But it also warned that many patients never find their way to care and that providers are often unaware of therapies that have proved their worth.
The commission also marshaled evidence of the crucial importance of ancillary services like supported housing and employment and income-support programs for the severely ill. But it candidly acknowledged that management of these services is in most cases hopelessly fragmented among siloed government departments with no collaborative traditions. Read the rest of this entry »
Posted in
All Categories, Mental Health |
Post a Comment
| 5 Trackbacks
April 7th, 2008
Because the most glaring geographic variations in health care use have been observed in specialty and end-of-life care, policymakers have had trouble coming to terms with the work of John Wennberg and his Dartmouth colleagues. The questions the Dartmouth researchers raise about spending and quality are too disruptive, too threatening. Specialty and end-of-life care are too sensitive for the blunt instruments of policy to address.
But with publication today of the latest edition of the Dartmouth Atlas, focused on chronic care, Wennberg and company carry their analysis to the most fundamental, everyday questions about the organization and delivery of care. The new Atlas joins the battle for health system improvement on a level that everyone can understand. It engages with questions that have immediate meaning for Congress, consumers, and many medical professionals and throws its weight behind policy proposals that already have widespread support. Wennberg is no longer a lonely voice crying out in the wilderness. Read the rest of this entry »
Posted in
All Categories, Cost, Hospitals, Physicians, Quality |
4 Comments
|
Show Commenters
| 3 Trackbacks
March 28th, 2008
Health Affairs and its publisher Project HOPE are pleased to announce that Susan Dentzer will become the journal’s new editor-in-chief on May 1, 2008.
Dentzer, one of the nation’s most respected health policy journalists, is currently an on-air correspondent for The NewsHour with Jim Lehrer on the Public Broadcasting Service. She heads The NewsHour’s health unit, which she helped create in 1998, and appears frequently on other programs such as Nightline and The McLaughlin Group. Her nearly three decades of journalistic experience span both broadcast and print media and include service as the chief economics correspondent at U.S. News & World Report and a senior business writer at Newsweek.
Dentzer has spoken on health care and other policy issues to a wide array of governmental, professional, and educational groups, and she has moderated panel discussions on key policy questions for organizations such as the AARP and the BlueCross BlueShield Association. She was selected through a process led by Health Affairs Founding Editor John Iglehart and will succeed Jamie Robinson, who is returning to his previous position as the Kaiser Permanente Distinguished Professor of Health Economics at the University of California, Berkeley, School of Public Health. Read the rest of this entry »
Posted in
All Categories |
2 Comments
|
Show Commenters
| 3 Trackbacks
March 28th, 2008
As Jacob, one of the three Old Testament patriarchs, flees from his brother Esau, he stops for the night at Bethel, where he dreams of a ladder going from earth to heaven with the angels of God ascending and descending the ladder (Genesis 28:11-19). There is extensive biblical commentary on this dream and particularly on why the angels are first ascending and then descending.
However, as anyone who follows the research on economic mobility and social determinants of health knows, you are always better off ascending the ladder rather than descending it. The spiritual “Jacob’s Ladder” also used the imagery of the ladder to symbolize the climb out of slavery and into freedom. Read the rest of this entry »
Posted in
All Categories, Disparities, Nonmedical Determinants |
Post a Comment
| 1 Trackback
March 26th, 2008
A lot of pipe dreams have been stoked by the seductive notion of “aligning incentives” — a catchphrase of the managed care era that promised better quality and lower costs in one magical bubble. But the divergent interests of patients, payers, and providers are in reality more likely to collide than align, a circumstance that has consigned most of this well-intentioned abstraction to the recycling bin.
In recent years, this journal has documented an increasingly competitive medical marketplace. While cheered by market fundamentalists, this wave of entrepreneurial enthusiasm has problematic implications for the critical issues of fragmentation of care and perverse incentives to overtreat. The most troubling of these has been the deepening of fault lines between hospitals and physicians. Read the rest of this entry »
Posted in
All Categories, Hospitals, Payment, Physicians |
Post a Comment
| 2 Trackbacks
|
|
May 14th, 2008
Editor’s Note: In connection with the publication of its May/June issue, a thematic issue on health reform, Health Affairs organized a May 5 conference call on the role of health reform in the presidential election. The call was moderated by Health Affairs editor-in-chief Susan Dentzer. Participants included Robert Blendon, a professor of health policy and political analysis at Harvard University and director of the Harvard Program on Public Opinion and Health and Social Policy; Robert Laszewski, the president of Health Policy and Strategy Associates Inc. and the author of the widely respected blog Health Care Policy and Marketplace Review; and Julie Rovner, a health policy correspondent for National Public Radio and a contributing editor for National Journal’s CongressDaily.
The transcript of the call appears below, and a shorter post featuring highlights from the call is also available. Check the Health Affairs Blog in the coming days for more blogging based on the new Health Affairs issue and on the May 13 event on health reform sponsored by the journal.
SUSAN DENTZER: How is the debate over health care reform playing in the current election campaign? Bob Blendon, since you have your finger on the pulse of the American public, let’s start with you.
ROBERT BLENDON: I think health care reform is part of the split that we see in who’s voting for Senator Obama and who’s voting for Senator Clinton, but it’s not the way we normally describe it. The differentiation is not around the policy debate about who has a particular mandate or not in his or her plan. It’s around who’s likely to carry the battle through. Read the rest of this entry »
Posted in
All Categories, Health Reform, Politics, Public Opinion |
Post a Comment
|
May 1st, 2008
In May 2007, Indiana enacted comprehensive health reform in the form of the Indiana Check-Up Plan and its centerpiece, the Healthy Indiana Plan (HIP). After intense negotiations, the Centers for Medicare and Medicaid Services granted Indiana the 1115b waiver required for the plan to go into effect in December 2007, and within three months over 30,000 Hoosiers had applied for the program.
HIP is the first Medicaid expansion in the nation to be modeled in the spirit of a high deductible health plan (HDHP)/ health savings account (HSA). This structure melds two themes of American society that typically collide in our healthcare system, rugged individualism and the Judeo Christian ethic. HIP combines these diametrically opposed themes by promoting personal responsibility while providing subsidized health protection to those who can least afford it. Read the rest of this entry »
Posted in
All Categories, Coverage, Health Reform, Medicaid, States |
5 Comments |
Show Commenters
| 1 Trackback
April 23rd, 2008
Editor’s Note: Should drugmakers and medical device manufacturers be allowed to provide physicians with medical and scientific journal articles concerning uses of their products that have not been approved by the Food and Drug Administration? Recently, the FDA issued draft guidance that would permit this practice with certain regulatory restraints. In the post below, Jerome Kassirer argues that the guidance would allow the distribution of potentially biased information and would discourage rigorous FDA review of new uses of drugs and devices. Scott Gottlieb, however, argues that the guidance would facilitate access to potentially life-saving information while ensuring that any research distributed is credible and transparent.
Two of the principal criteria of the Food and Drug Administration’s (FDA’s) new guidance on distribution of reprints describing off-label drug use are that the journal of origin must be peer reviewed and have a disclosure policy. The notion that peer review and disclosure will protect the public is, in my judgment, magical thinking. Anthropologist Philips Stevens Jr. says that magical thinking invests symbols with special powers and forces. Peer review and disclosure are two of these powerful symbols, and, in my opinion, both have been afforded far more credibility than they deserve. Read the rest of this entry »
Posted in
All Categories, Pharma, Politics, Technology |
Post a Comment
| 1 Trackback
April 23rd, 2008
Editor’s Note: Should drugmakers and medical device manufacturers be allowed to provide physicians with medical and scientific journal articles concerning uses of their products that have not been approved by the Food and Drug Administration? Recently, the FDA issued draft guidance that would permit this practice within certain regulatory restraints. In the post below, Scott Gottlieb argues that the guidance would facilitate access to potentially life-saving information while ensuring that any research distributed is credible and transparent. Jerome Kassirer, however, argues that the guidance would allow the distribution of potentially biased information and would discourage rigorous FDA review of new uses of drugs and devices.
In early 2005, results of a large, government-run study showed that when the breast cancer drug Herceptin was used after surgery in the treatment of certain early-stage tumors, it could cut their chances of relapsing in half. It was a dramatic result. Herceptin, which was developed by Genentech, had been used for years in patients with advanced breast cancers, and with good results. But this was the first significant study to show that when the drug was used in the earlier stages of the disease, its benefits could be even more impressive.
It is rare in the practice of medicine that the introduction of a single treatment can produce such significant benefits relative to its known risks. In breast cancer, perhaps only tamoxifen (administered for five years to patients with estrogen-receptor–positive primary breast cancer) produces as significant of a reduction in the risk of cancer recurrence. The New England Journal of Medicine, in an editorial, called the studies with Herceptin “not evolutionary but revolutionary.” The results resonated around the cancer community. Read the rest of this entry »
Posted in
All Categories, Pharma, Politics, Technology |
Post a Comment
| 2 Trackbacks
April 2nd, 2008
Americans need and deserve health information technology (IT). As the chairman and CEO of Verizon Communications Inc. and the only business representative on a federal commission to develop a strategy for health care IT standards, I have spent considerable time over the past several years promoting this technological necessity.
In addition, Verizon helped found an unprecedented, broad-based coalition of health associations, consumer groups, labor unions, patient organizations, and other businesses to urge Congress to pass a health IT bill. I’m also the chairman of the Health and Retirement Task Force of the Business Roundtable, so on Wednesday (April 2) I will join Sen. Edward Kennedy (D-MA), Sen. Mike Enzi (R-WY), and Ron Williams, chairman and CEO of Aetna, to urge Congress to pass the Wired for Health Care Quality Act, authored by Senators Kennedy and Enzi. Read the rest of this entry »
Posted in
All Categories, Health IT, Policy, Politics, Uncategorized |
6 Comments |
Show Commenters
| 2 Trackbacks
March 31st, 2008
Editor’s Note: This post was written by several of the 2007-08 Commonwealth Fund Harkness Fellows. These fellowships allow mid-career health services researchers and practitioners from Australia, Germany, the Netherlands, New Zealand, and the United Kingdom to spend up to 12 months in the United States, conducting original research and working with leading U.S. health policy experts. The lead authors of the post are Richard Gleave and Geraint Lewis. Additional authors include Kalipso Chalkidou, Andreas Gerber, Ruth McDonald, and Rhema Vaithianathan.
A recent article in the New York Times (“Paying Patients Test British Health Care System,” 21 February 2008) demonstrated a bias in the reporting of an international health care issue. The article focused on the case of a terminally ill woman in England who was prevented from paying privately for a high-cost cancer drug (Avastin) whilst she was being treated by the National Health Service (NHS).
The article broached three separate issues: (1) access to expensive drugs and technologies; (2) cost-effectiveness evaluation of new drugs and technologies; and (3) private top-up within public health care provision [supplementing publicly provided services with private services paid for out of pocket]. Each of these topics is relevant to the health care reform debate in the United States, but the way in which the article confounded the three distorted the issues. Read the rest of this entry »
Posted in
Access, All Categories, Cost, Policy |
2 Comments |
Show Commenters
| 3 Trackbacks | |